Joshua Brody/X
Sep 5, 2024, 05:09
Joshua Brody: Excited for the CME event on CAR T-cell therapy for lymphoma and CLL at SOHO2024
Joshua Brody shared on LinkedIn:
“Excited for the Amps-to-go-up-to-11 at tomorrow’s CME event on CAR T-cell therapy for lymphoma and CLL with Research To Practice, Jason Westin, and Matt Lunning at SOHO2024!”
Read Further.
Source: Joshua Brody/LinkedIn
Joshua Brody, MD, is the Director of the Lymphoma Immunotherapy Program at The Tisch Cancer Institute at Mount Sinai and a faculty member at the Icahn Genomics Institute. He has established a comprehensive clinical program and a Cancer Immunotherapy Lab focused on basic and applied tumor immunology. His lab investigates novel therapies for lymphomas, breast cancer, and head/neck cancer, with results published in leading scientific journals.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 11:52
Dec 21, 2024, 11:30
Dec 21, 2024, 11:25
Dec 21, 2024, 11:18
Dec 21, 2024, 11:12
Dec 21, 2024, 11:06